Short answer
FENNEC PHARMACEUTICALS INC. (FENC) filed an 8-K current report with the SEC on May 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). 50,000 stock options granted to three new employees under the 2026 Equity Inducement Plan.
FENNEC PHARMACEUTICALS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- 50,000 stock options granted to three new employees under the 2026 Equity Inducement Plan
- $9.75 exercise price, ten-year term, and three-year vesting schedule
- One-third vests after year one, remainder monthly over 24 months, contingent on continued employment
- Nasdaq Rule 5635(c)(4) inducement awards support hiring while creating potential future share dilution
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FENNEC PHARMACEUTICALS INC. 8-K filings
Get the next FENC 8-K as it lands
Follow FENC for push alerts, or ask the research agent what this filing means.